Final Programme

Postgraduate Educational Programme
08:30 - 10:00 Room K
Special Focus Session
SF 1c
Imaging in dementia: An emerging role for the radiologist?
Moderator: E.-M.B. Larsson; Aalborg/DK
A-031 08:30
Imaging in dementia: An emerging role for the radiologist? (Introduction)
E.-M.B. Larsson; Aalborg/DK
Session Objectives:
1. To understand the role of imaging for early diagnosis of Alzheimer’s disease and other degenerative
dementia disorders.
2. To learn how imaging can be used in the differentiation between different dementia disorders
(degenerative and vascular).
3. To understand the usefulness of quantitative imaging in the evaluation of dementia.
A-032 08:35
The role of imaging for early diagnosis of Alzheimer’s disease
B. Gómez-Ansón; Barcelona/ES
Learning Objectives:
1. To illustrate the role of structural and functional neuroimaging techniques, including MRI, MRS, fMRI,
SPECT and PET, for early diagnosis of diseases causing cognitive decline.
2. To demonstrate how these techniques may contribute to early diagnosis of the recently recognised
preclinical stages of Alzheimer’s disease (AD): Mild cognitive impairment (MCI) and the prodromal stages
of AD.
3. To briefl y discuss how neuroimaging may increase our knowledge about the asymptomatic stages of
genetic dementia disorders, such as Huntington’s disease.
A-033 09:00
Differentiation between dementia disorders: Imaging support
F. Barkhof; Amsterdam/NL
Learning Objectives:
1. To understand the indications for (structural) imaging in the differential diagnosis of dementia.
2. To be able to design a comprehensive MRI protocol for dementia.
3. To learn to systematically report dementia scans, including vascular loading and regional patterns of
atrophy.
4. To understand the sensitivity and specifi city of MRI for Alzheimer’s disease and other common dementias.
A-034 09:25
Quantitative imaging in dementia
H.R. Jäger; London/UK
Learning Objectives:
1. To acquire a basic knowledge of quantitative imaging parameters applicable to the imaging of dementia,
including the apparent diffusion coeffi cient (ADC), fractional anisotropy (FA), relative cerebral blood
volume (rCBV), magnetisation transfer ratio (MTR) and volumetric measurements.
2. To learn about regional differences of these parameters between normal volunteers and patients with
Alzheimer’s disease, fronto-temporal dementia and other types of dementia.
3. To understand the principles of quantitative assessment of brain volume changes over time (imaging of
the 4th dimension) and their relevance in the diagnosis of dementia.
4. To understand the role diffusion-weighted imaging in the differential diagnosis of rarer forms of dementia
such as Creutzfeld Jacob disease (CJD).
Panel discussion 09:50
myESR.org
A B C D 145
Friday